CleveMed’s NeuroSense line is undergoing testing in the U.S. and Europe and is awaiting clearance for sale in both locations, according to the report. It is still developing its seizure detection products.
Read the Crain’s report about CleveMed’s license agreement with NeuroWave.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.